MARC details
| 000 -LEADER |
|---|
| fixed length control field |
07186cam a22005294i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
1263610 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
EG-GaU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20211103101425.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
041119s2005 ii a b 101 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2004062719 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780841238992 (alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0841238995 (alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0195686985 (alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978195686985 (alk. paper) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)57069166 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Transcribing agency |
DLC |
| Modifying agency |
OCLCQ |
| -- |
UKM |
| -- |
BAKER |
| -- |
C#P |
| -- |
EG-GaU |
| Language of cataloging |
eng |
| Description conventions |
rda |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
23 |
| Classification number |
615.2 |
| Item number |
M.E.D. |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Medicinal inorganic chemistry / |
| Statement of responsibility, etc. |
Editor Jonathan L. Sessler, Susan R. Doctrow, Thomas J. McMurry, Stephen J. Lippard. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New Delhi : |
| Name of producer, publisher, distributor, manufacturer |
American Chemical Society : |
| -- |
Distributed by CBS publishers & Distributors, |
| Date of production, publication, distribution, manufacture, or copyright notice |
c2005. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
ix, 453 pages, [8] pages of plates : |
| Other physical details |
illustrations (some color) ; |
| Dimensions |
24 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
ACS symposium series ; |
| Volume/sequential designation |
903 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
"Sponsored by the ACS Divisions of Inorganic Chemistry, Inc. and Medicinal Chemistry." |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and indexes. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Title |
1. Metal Ion Chemistry for Sustaining Life / |
| Statement of responsibility |
Stephen J. Lippard -- |
| Title |
2. Medicinal Inorganic Chemistry: Promises and Challenges / |
| Statement of responsibility |
John W. Kozarich -- |
| Title |
3. Metals in Medicine: Biomedical Significance and Inorganic Chemistry / |
| Statement of responsibility |
Peter C. Preusch -- |
| Title |
4. Discovery and Development of Third-Generation Platinum Antitumor Agents with Oral Activity / |
| Statement of responsibility |
Christen M. Giandomenico and Ernest Wong -- |
| Title |
5. Brain Iron as an Endrogenous Contrast Agent in High Field MRI / |
| Statement of responsibility |
John F. Schenck -- |
| Title |
6. Platinum Anticancer Drugs: From Laboratory to Clinic / |
| Statement of responsibility |
Nicholas Farrell -- |
| Title |
7. Mechanistic Studies of Pt and Ru Compounds with Antitumor Properties / |
| Statement of responsibility |
Jan Reedik -- |
| Title |
8. Mechanistic Studies of Motexafin Gadolinium (Xcyrin): A Redox Active Agent That Reacts with Electron-Rich Biological Substrates / |
| Statement of responsibility |
Darren J. Magda, Nikolay Gerasimchuk, Zhong Wang, Jonathan L. Sessler, and Richard A. Miller -- |
| Title |
9. Bile Acids at Work: Development of a New Intravascular MRI Contrast Agent / |
| Statement of responsibility |
Pier Lucio Anelli, Marino Brocchetta, Vito Lorusso, Giuseppe Manfredi, Alberto Morisetti, Pierfrancesco Morosini, Marcella Murru, Daniela Palano, and Massimo Visigalli -- |
| Title |
10. Water Exchange is the Key Parameter in the Design of Next-Generation MRI Agents / |
| Statement of responsibility |
A. Dean Sherry, Shanrong Zhang, and Mark Woods -- |
| Title |
11. Targeted Molecular Imaging with MRI / |
| Statement of responsibility |
Peter Caravan -- |
| Title |
12. Synthesis and Development of Gadomer: A Dendritic MRI Contrast Agent / |
| Statement of responsibility |
Johannes Platzek and Heribert Schmitt-Willich -- |
| Title |
13. Amyloid Precursor Protein and Ferritin Translation: Implications for Metals and Alzheimer's Disease Therapeutics / |
| Statement of responsibility |
Jack T. Rogers -- |
| Title |
14. Anticopper Therapy with Tetrathiomolybdate for Wilson's Disease, Cancer, and Diseases of Inflammation and Fibrosis / |
| Statement of responsibility |
George J. Brewer -- |
| Title |
15. Heme Detoxification in Malaria: A Target Rich Environment / |
| Statement of responsibility |
Clare Kenny Carney, Lisa Pasierb, and David Wright -- |
| Title |
16. Heme as a Trigger and Target of the Antimalarial Peroxide Artemisinin / |
| Statement of responsibility |
Anne Robert, Francoise Benoit-Vical, and Bernard Meunier -- |
| Title |
17. Administration of Mn Polyyrin and Mn Texaphyrin at Symptom Onset Extends Survival of ALS Mice / |
| Statement of responsibility |
John P. Crow - |
| Title |
18. Salen Manganese Complexes: Multifunctional Catalytic Antioxidants Protective in Models for Neurodegenerative Diseases of Aging / |
| Statement of responsibility |
Susan R. Doctorow, Michael Baudry, Karl Huffman, Bernard Malfroy, and Simon Melov -- |
| Title |
19. Metal Deficient Copper-Zinc Superixide Dismutase and Familial Amyotrophic Lateral Sclerosis: Pathogenic SOD1 Oligomerization through Non-Native Protein-Protein Interactions / |
| Statement of responsibility |
P. John Hart and Joan Selverstone Valentine -- |
| Title |
20. Impact of the Lipophilicity of Desferrithiocin Anaglogues on Iron Clearance / |
| Statement of responsibility |
Raymond J. Bergeron, Jan Wiegand, James S. McManis, William R. Weimar, Jeong-Hyun Park, Eileen Eiler-McManis, Jennifer Bergeron, and Gary M. Brittenham -- |
| Title |
21. In Vivo Coordination Chemistry and Biocalization of Bis(ligand)oxovanadium(IV) Complexes for Diabetes Treatment / |
| Statement of responsibility |
Katherine H. Thompson, Barry D. Liboiron, Graeme R. Hanson, and Chris Orvig -- |
| Title |
22. Targeting Melanoma via Metal-Based Stress / |
| Statement of responsibility |
Patrick J. Farmer, Daniel Brayton, Christina Moore, Donny Williams, Babbak Shahandeh, Dazhi Cen, and Frank Meyskens, Jr. -- |
| Title |
23. Medicinal Applications of Metal Complexes of N-Heterocyclic Carbenes / |
| Statement of responsibility |
Wiley J. Youngs, Claire A. Tesslier, Jared C. Garrison, Carol A. Quezada, Abdulkareem Melaiye, Semih Durmus, Matthew J. Panzer, and Aysegul Kascatan-Nebioglu. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"This book, a compilation by experts in the field, is designed to provide an introduction to the area of medicinal inorganic chemistry and to summarize current, state-of-the-art developments in the field. Medicinal inorganic chemistry represents a key thrust area in medicine and biological inorganic chemistry. It is one of great current excitement and achievement. The field of metals in medicine represents an approximate $3 billion dollar a year industry, with successes in the area of Tc- and Gd-based imaging agents and Pt-based cancer therapeutics being major contributors to this bottom line. It has become increasingly apparent, however, that metal-based pharmaceuticals can play a prominent role in areas outside of imaging and oncology, including in those associated with the diagnosis and treatment of metabolism- and genetic disorders, cardiovascular disease, gene therapy, inflammation, reperfusion injury, stroke, diabetes, ALS, malaria, and neurological disease to name but a few. A objective of this book, therefore, is to highlight these opportunities for future advances and to foster further interactions between those working in the metal-based drug development, including imaging agents, and those engaged in the more classic pharmaceutical industries."--Publisher description. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Inorganic Chemicals |
| General subdivision |
pharmacology |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D007287Q000494 |
| 9 (RLIN) |
1424 |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Organometallic Compounds |
| General subdivision |
pharmacology |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D009942Q000494 |
| 9 (RLIN) |
1425 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Inorganic Chemicals |
| General subdivision |
therapeutic use |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D007287Q000627 |
| 9 (RLIN) |
1426 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Minerals |
| General subdivision |
pharmacology |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D008903Q000494 |
| 9 (RLIN) |
1427 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Organometallic Compounds |
| General subdivision |
therapeutic use |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D009942Q000627 |
| 9 (RLIN) |
1428 |
| 655 #2 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Congress |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D016423 |
| 9 (RLIN) |
1429 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Sessler, Jonathan L., |
| Relator term |
editor. |
| 9 (RLIN) |
1430 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Doctrow, Susan R., |
| Relator term |
editor. |
| 9 (RLIN) |
1431 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
McMurry, Thomas J., |
| Relator term |
editor. |
| 9 (RLIN) |
1432 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lippard, Stephen J., |
| Relator term |
editor. |
| 9 (RLIN) |
1433 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
American Chemical Society. |
| Subordinate unit |
Division of Inorganic Chemistry. |
| 9 (RLIN) |
1434 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
American Chemical Society. |
| Subordinate unit |
Division of Medicinal Chemistry. |
| 9 (RLIN) |
1435 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
ACS symposium series ; |
| Volume/sequential designation |
903. |
| 9 (RLIN) |
1436 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://library.gu.edu.eg/cgi-bin/koha/opac-retrieve-file.pl?id=cf0e265b9673df79ecb8001585e2e391">https://library.gu.edu.eg/cgi-bin/koha/opac-retrieve-file.pl?id=cf0e265b9673df79ecb8001585e2e391</a> |
| Public note |
Get the E-Book |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |